Alzheimer Drug Research Continues Despite Setbacks; New UCLA Study Says 1M Californians Lost Job-Based Health Care in Recession - Health Minute for November 5, 2012

Primary tabs

3BL Media, LLC
Keywords: 3bl Media | Healthcare Institutional News | Alzheimer | California | Drug Research | Health | Health Minute | Healthcare | Recession | UCLA | jobs

Alzheimer Drug Research Continues Despite Setbacks; New UCLA Study Says 1M Californians Lost Job-Based Health Care in Recession - Health Minute for November 5, 2012

tweet me:
#Alzheimer drug research continues; New @UCLA study says 1M Californians Lost Job-Based #healthcare in Recession http://3bl.me/se5x4d
Multimedia from this Release
Press Release
Monday, November 5, 2012 - 12:00pm

A new report has found that Alzheimer’s drug research has resulted in only three drugs brought to market out of 101 drugs that were in development to treat the disease over the last 13 years. The study, by the Pharmaceutical Research and Manufacturers of America, also notes that there are 93 new meds in the pipeline, and that biopharma shows no signs of letting up in the hunt for treatments against Alzheimer’s, which afflicts five million Americans who currently have access to only five approved drugs for symptoms of the disease.

More than one million Californians have lost job-based health insurance during the recession, according to a new study from the UCLA Center for Health Policy Research. The percentage of Californians who had insurance through their own or a family member’s employment fell below 50 percent for the first time in ten years. The report also found that the percentage of non-elderly adults and children enrolled in Medi-Cal and the state’s Healthy Families program increased, with one in five insured through these public health insurance program for low-income Californians.

For more information on these and other stories, go to 3blmedia.com

Video Source: Alzheimer Drug Research Continues Despite Setbacks; New UCLA Study Says 1M Californians Lost Job-Based Health Care in Recession